1st Quarter - Amendment — MEDCO HEALTH SOLUTIONS, INC for MEDCO HEALTH SOLUTIONS INC (2009)

Firm

MEDCO HEALTH SOLUTIONS, INC

Client

MEDCO HEALTH SOLUTIONS INC

Income

—

Expenses

$990,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 17, 2009	$990,000,000	Replaced
1st Quarter - Amendment (this page)	Apr 20, 2009	$990,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health Information Technology, HIPAA Privacy and Security Rules, Biogenerics, Comparative Effectivesness, Chronic Care Management HR 1 - American Recovery and Reinvestment Act of 2009; Title VIII Departments of Labor, Health and Human Services, and Education, and Related Agencies, Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act HR 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections. HR 1548 - Pathway for Biosimilars Act; all aspects

Lobbyist	Covered position, as disclosed
PETER BEGANS	—
ALLYSON BLANDFORD	—
BILL HEAD	—
KIMBERLY LINTHICUM	—
HEATHER STEWART	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1 (111th), S. 726 (111th), H.R. 1548 (111th), H.R. 1427 (111th)

Medicare/Medicaid MMM

Medicare Part D, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment, Importation of Prescription Drugs HR 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all aspects HR 1204 - Community Pharmacy Fairness Act of 2009; all sections HR 1765 - To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009; all aspects

Lobbyist	Covered position, as disclosed
PETER BEGANS	—
ALLYSON BLANDFORD	—
BILL HEAD	—
KIMBERLY LINTHICUM	—
HEATHER STEWART	—

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: S. 525 (111th), H.R. 1765 (111th), H.R. 574 (111th), H.R. 1204 (111th), S. 254 (111th)

Pharmacy PHA

Electronic Prescribing, Mail Order Pharmacy HR 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act

Lobbyist	Covered position, as disclosed
PETER BEGANS	—
ALLYSON BLANDFORD	—
BILL HEAD	—
KIMBERLY LINTHICUM	—
HEATHER STEWART	—

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: H.R. 1 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.